Bayesian Capital Management’s Claritev Corp CTEV Stock Holding History
Bought
Maintained
Sold
Other funds holding CTEV
HFCIV
PIF
LGP
PGH
CP
AM
Bayesian Capital Management's CTEV Position: Q4 2022 in Review
Bayesian Capital Management sold out of Claritev Corp (CTEV) in Q4 2022, closing a stake of 343 shares — an estimated $39K sold.
Bayesian Capital Management first reported a position in CTEV in Q4 2021 and held it in 3 quarters. The position peaked at $160K in Q4 2021. 130 funds tracked by Wall St. Rank hold CTEV as of Q4 2022.
- Bayesian Capital Management reported no remaining Claritev Corp position as of Q4 2022 after selling out during the quarter.
- Bayesian Capital Management sold 343 Claritev Corp shares in Q4 2022, an estimated $39K.
- Bayesian Capital Management first reported a position in Claritev Corp in Q4 2021 and held it in 3 quarters.
- Bayesian Capital Management's Claritev Corp position peaked at $160K in Q4 2021.
- 130 funds tracked by Wall St. Rank held Claritev Corp as of Q4 2022.
Based on Bayesian Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.